parkinson disease

Showing NaN - NaN of 47

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Parkinson Disease, Parkinson's Disease and Parkinsonism Trial in United States (Non-invasive brainstem stimulation)

Recruiting
  • Parkinson Disease
  • Parkinson's Disease and Parkinsonism
  • Non-invasive brainstem stimulation
  • Scottsdale, Arizona
  • +18 more
Jan 26, 2023

Parkinson Disease Trial in Worldwide (Tavapadon, Placebo)

Recruiting
  • Parkinson Disease
  • Phoenix, Arizona
  • +145 more
Dec 20, 2022

Parkinson Disease Trial in Worldwide (Tavapadon)

Enrolling by invitation
  • Parkinson Disease
  • Birmingham, Alabama
  • +114 more
Dec 20, 2022

Parkinson Disease, Healthy Participants Trial in United States (TAK-071, Placebo)

Active, not recruiting
  • Parkinson Disease
  • Healthy Participants
  • Garden Grove, California
  • +20 more
Nov 30, 2022

Parkinson Disease Trial in Worldwide (APL-130277)

Completed
  • Parkinson Disease
  • Birmingham, Alabama
  • +69 more
Nov 11, 2022

Parkinson Disease, Parkinson's Disease and Parkinsonism Trial in United States (Open Label Extension Study)

Enrolling by invitation
  • Parkinson Disease
  • Parkinson's Disease and Parkinsonism
  • Open Label Extension Study
  • Scottsdale, Arizona
  • +14 more
Oct 24, 2022

PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

Recruiting
  • Parkinson Disease
    • Birmingham, Alabama
    • +50 more
    Jul 26, 2022

    Parkinson Disease Trial in Worldwide (Omnidirectional stimulation, Directional stimulation)

    Completed
    • Parkinson Disease
    • Omnidirectional stimulation
    • Directional stimulation
    • Sacramento, California
    • +48 more
    Jun 28, 2022

    Parkinson Disease Trial in New York, Houston (Spinal Cord Stimulator (SCS))

    Recruiting
    • Parkinson Disease
    • Spinal Cord Stimulator (SCS)
    • New York, New York
    • +1 more
    Apr 18, 2022

    Parkinson Disease Trial in Worldwide (IPX203 140 mg, IPX203 210 mg, IPX203 280 mg)

    Completed
    • Parkinson Disease
    • IPX203 140 mg
    • +3 more
    • Phoenix, Arizona
    • +97 more
    Apr 5, 2022

    Constipation, Parkinson Disease Trial in United States (Active Investigational Treatment ENT-01, Placebo Treatment)

    Completed
    • Constipation
    • Parkinson Disease
    • Active Investigational Treatment ENT-01
    • Placebo Treatment
    • Sun City, Arizona
    • +50 more
    Mar 21, 2022

    Wearable Assessments in the Clinic and Home in PD

    Active, not recruiting
    • Parkinson Disease
      • Sun City, Arizona
      • +16 more
      Mar 9, 2022

      Parkinson Disease Trial in United States (Personal KinetiGraph® (PKG®) Watch, Personal KinetiGraph® (PKG®) Report)

      Terminated
      • Parkinson Disease
      • Personal KinetiGraph® (PKG®) Watch
      • Personal KinetiGraph® (PKG®) Report
      • Fayetteville, Arkansas
      • +16 more
      Jan 12, 2022

      Parkinson Disease Trial in United States (SAGE-217, Levodopa, Antiparkinsonian Agent(s))

      Completed
      • Parkinson Disease
      • Panorama City, California
      • +10 more
      Jan 20, 2022

      Parkinson Disease Trial in Houston (PRIM-DJ2727, Placebo oral capsule)

      Active, not recruiting
      • Parkinson Disease
      • Houston, Texas
        The University of Texas Health Science Center at Houston
      Dec 23, 2021

      Parkinson Disease Trial in Worldwide (Tavapadon, Placebo)

      Recruiting
      • Parkinson Disease
      • Fresno, California
      • +55 more
      Sep 8, 2021

      Parkinson Disease Trial in Worldwide (Tavapadon, Placebo)

      Recruiting
      • Parkinson Disease
      • Birmingham, Alabama
      • +91 more
      Sep 8, 2021

      Parkinson Disease Trial in Worldwide (THN102 Dosage A, THN102 Dosage B, THN102 Dosage C)

      Completed
      • Parkinson Disease
      • THN102 Dosage A
      • +2 more
      • Kansas City, Kansas
      • +33 more
      Nov 27, 2020

      Parkinson Disease Trial in Worldwide (Placebo, PF-06649751 low dose (1 mg QD), PF-06649751 middle dose 1 (3 mg QD))

      Terminated
      • Parkinson Disease
      • Placebo
      • +4 more
      • Phoenix, Arizona
      • +56 more
      Oct 28, 2020

      Parkinson Disease Trial in Worldwide (Placebo, PF-06649751)

      Terminated
      • Parkinson Disease
      • Phoenix, Arizona
      • +36 more
      Oct 28, 2020

      Parkinson Disease Trial in United States (Cohort 1:Nilotinib Oral Capsules (150mg or 300mg), Cohort 2: Nilotinib Oral Capsules

      Completed
      • Parkinson Disease
      • Cohort 1:Nilotinib Oral Capsules (150mg or 300mg)
      • +2 more
      • Birmingham, Alabama
      • +23 more
      Jul 21, 2020

      Parkinson Disease Trial in Worldwide (DaTscan)

      Unknown status
      • Parkinson Disease
      • Birmingham, Alabama
      • +33 more
      Jul 15, 2020

      Parkinson Disease Trial in United States (Personal KinetiGraph™ (PKG™))

      Active, not recruiting
      • Parkinson Disease
      • Personal KinetiGraph™ (PKG™)
      • Sacramento, California
      • +11 more
      Mar 3, 2020

      Parkinson Disease Trial in Canada, United States (Isradipine, Placebo (for Isradipine))

      Completed
      • Parkinson Disease
      • Birmingham, Alabama
      • +53 more
      Jan 7, 2020

      Parkinson Disease Trial in Houston (Smartphone-based balance exercises)

      Unknown status
      • Parkinson Disease
      • Smartphone-based balance exercises
      • Houston, Texas
        Center for Neuromotor and Biomechanics Research
      Oct 28, 2019